Overview
Description
Devyser Diagnostics AB, a prominent biotechnology company, specializes in the development, manufacturing, and distribution of diagnostic test kits built on unique genetic testing technology. The primary function of Devyser Diagnostics AB's products is to provide rapid and reliable diagnostic solutions in areas such as hereditary diseases, oncology, and post-transplantation monitoring. By enabling comprehensive genetic analysis, these kits help healthcare professionals deliver precise disease diagnostics and personalized treatment plans. Devyser’s technology plays a critical role in clinical laboratories worldwide, enhancing the accuracy and efficiency of DNA analysis. The company’s focus on innovation and quality has established it as a key player within the molecular diagnostics industry, gaining a reputation for simplifying complex genetic tests into user-friendly formats. These advancements not only improve patient outcomes but also streamline operations within the healthcare sector, particularly in genomics and precision medicine. Through continuous research and development, Devyser Diagnostics AB remains at the forefront of molecular diagnostics, driving advancements in genetic testing that are essential for modern healthcare frameworks.
About
CEO
Dr. Fredrik Dahl Ph.D.
Employees
110
Address
Bränningevägen 12
Årsta, 120 54
Årsta, 120 54
Phone
46 8 56 21 58 50
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Diagnostics & Research
Country
Sweden
MIC code
XSTO